Tuesday, January 22, 2013

Kettenbach enters U.S. dental market


Kettenbach enters U.S. dental market

September 30, 2008 -- Kettenbach, a German producer of impression materials, will now sell its dental products direct to the U.S. dental market. The company's U.S. division is headquartered in Huntington Beach, CA.
To mark its entry into the U.S. dental market, Kettenbach has introduced its full line of Futar bite registration materials, including Futar D, the leading bite registration material in Germany, according to a company press release.
"Kettenbach has developed into a leading player in the global dental market within the impression material sector based on 60 years of experience," said Maribelle Velasco, vice president of sales, marketing, and operations for Kettenbach in the U.S.
The next product slated for direct sales in the U.S. is Silginat, a medium-bodied viscosity, polyvinyl siloxane impression material designed for a variety of indications, such as anatomical models, fabrication of temporary crown and bridges, orthodontic appliances, and case study models. Silginat will be introduced at the 2008 ADA meeting in San Antonio in October.

Copyright © 2008 DrBicuspid.com

Hoya ConBio offers replacement fibers for DioDent


Hoya ConBio offers replacement fibers for DioDent

September 30, 2008 -- Hoya ConBio announced the availability of a replacement fiber for the original DioDent dental laser models. The new highly flexible fiber is designed to provide optimum performance for a variety of soft-tissue dental procedures, according to the company.
Bendable tips enable easy posterior access, and a nick and fleck cleaving delivers fast fiber preparation and an assured flat fiber tip, the company noted. The fiber kit includes a fiber spool and mount to add to the existing system that conveniently stores the fiber. The new handpiece locks the fiber in place securely, preventing the fiber from pulling out or pushing in. The fingertip jacket stripping eliminates the need for tools.
The fiber is available as a replacement for the DioDent, DioDent II, and LVIlase models, and is already featured on the next-generation DioDent Micro 980 soft-tissue laser.

Copyright © 2008 DrBicuspid.com

Lack of antibiotics costs dentist $2.6 million


Lack of antibiotics costs dentist $2.6 million

September 29, 2008 -- An Oklahoma dentist's decision not to pretreat a diabetic patient with antibiotics prior to extracting her abscessed tooth may cost him $2.6 million. That is the amount a Comanche County jury has awarded the husband of Linda Culberson, who died in January 2004 from an infection after Robert Morford, D.D.S., of Lawton, OK, pulled her tooth.
Mrs. Culberson, 58, went to Dr. Morford's office in April 2002 with "a chronically abscessed tooth," according to Ed Culberson's attorney, Mike Markey. Dr. Morford opted to pull the tooth but did not give Mrs. Culberson any antibiotics. She then developed a "life-threatening infection," according to Markey. The infection became so serious that she spent 20 months on life support and died in January 2004. Mr. Culberson filed his malpractice lawsuit later that year.
The key issue put before the jury was whether Culberson should have been given antibiotics prior to the extraction, Markey said -- especially because she had poorly controlled diabetes. The ADA recommends that dentists "consider systemic antibiotics for uncontrolled diabetic patients who have frequent infections or heal poorly," and numerous studies have found that infection is a risk for diabetic patients and can make it more difficult to control blood glucose levels. For example, a 2000 study published in the Journal of the American Dental Association concluded that, because insulin-dependent diabetics are particularly susceptible to infections, "antibiotic coverage for invasive dental procedures is recommended in patients with poorly controlled or uncontrolled diabetes" (JADA, March 2000, Vol. 131:3, pp. 366-374).
"The defendant's position was that the antibiotics weren't necessary, and our position was that they were, given her history of health problems," Markey said.
However, the jury found that Mr. Culberson was partly at fault because he did not adequately inform Dr. Morford of Mrs. Culberson's diabetes, Markey said. Culberson's lawsuit originally sought $4 million in damages.
"The jury found that there was some negligence on the part of the husband," Markey said. "One of the issues they raised is that he should have gotten her to the dentist sooner."
Michael Hill, Dr. Morford's attorney, told DrBicuspid.com that Dr. Morford met the standard of care in that removing the source of the infection -- the tooth -- was the appropriate treatment for the infection, and that antibiotics were not required.
"We did then, and do now, feel as though Dr. Morford met the standard of care," Hill said.
The verdict could be appealed, according to Markey. The court is already considering various post-trial motions, Hill said.